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Abstract
Background: In 2009 a total of 153,408 malaria deaths were reported in Africa. Eleven countries showed a
reduction of more than 50% in either confirmed malaria cases or malaria admissions and deaths in recent years.
However, many African countries are not on track to achieve the malaria component of the Millennium
Development Goal (MDG) 6. The African Leaders Malaria Alliance (ALMA) working session at the 15
th African Union
Summit discussed the bottlenecks to achieving MDG 6 (specifically halting and beginning to reverse the incidence
of malaria by 2015), success factors, and what countries needed to do to accelerate achievement of the MDG. The
purpose of this article is to reflect on the proceedings of the ALMA working session.
Methods: Working methods of the session included speeches and statements by invited speakers and high-level
panel discussions.
Discussion: The main bottlenecks identified related to the capacity of the health systems to deliver quality care
and accessibility issues; need for strong, decentralized malaria-control programmes with linkages with other health
and development sectors, the civil society and private sector entities; benefits of co-implementation of malaria
control programmes with child survival or other public health interventions; systematic application of integrated
promotive, preventive, diagnostic and case management interventions with full community participation; adapting
approaches to local political, socio-cultural and administrative environments.
The following prerequisites for success were identified: a clear vision and effective leadership of national malaria
control programmes; high level political commitment to ensure adequate capacity in expertise, skill mix and
number of managers, technicians and service providers; national ownership, intersectoral collaboration and
accountability, as well as strong civil society and private sector involvement; functional epidemiological surveillance
systems; and levering of African Union and regional economic communities to address the cross-border dimension
of malaria control.
It was agreed that countries needed to secure adequate domestic and external funding for sustained commitment
to malaria elimination; strengthen national malaria control programmes in the context of broader health system
strengthening; ensure free access to long-lasting insecticide treated nets and malaria diagnosis and treatment for
vulnerable groups; strengthen human resource capacity at central, district and community levels; and establish
strong logistics, information and surveillance systems.
Conclusion: It is critically important for countries to have a clear vision and strategy for malaria elimination;
effective leadership of national malaria control programmes; draw lessons from other African countries that have
succeeded to dramatically reduce the burden of malaria; and sustain funding and ongoing interventions.
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Dr Gro Harlem Brundtland, the then Director-General
of the World Health Organization (WHO), identified
Roll Back Malaria (RBM) as a priority project of the
renewed WHO and established it as such on 23 July
1998 [1]. The goal of RBM was to contribute to
strengthen national health systems working to signifi-
cantly reduce the burden of disease associated with
malaria through better access of poor people to a range
of effective antimalaria interventions. The global part-
nership for RBM was established at a meeting in Gen-
eva, 8–9 December 1998. The membership is drawn
from representatives of countries affected by malaria,
organizations of the United Nations system, bilateral
development agencies, development banks, nongovern-
mental organizations and the private sector. RBM is
committed to a common purpose, ways of working and
outcomes.
In September 2000 the UN added efforts to fight
malaria to the Millennium Development Goals (MDGs)
[2]. On 25 April 2000 African Heads of State and Gov-
ernment at the African Summit on Roll Back Malaria in
Abuja, Nigeria, signed the Abuja Declaration and Plan
of Action with a firm commitment to halve malaria
mortality for Africa’sp e o p l eb y2 0 1 0[ 3 ] .T h eA f r i c a n
leaders also declared 25th April of each year as “Africa
Malaria Day”. The Assembly of the African Union
adopted a declaration on Malaria, HIV/AIDS, Tubercu-
losis and Other Related Infectious Diseases at its second
ordinary session held in Maputo, Mozambique, 10–12
July 2003 [4]. In May 2005, the World Health Assembly
endorsed the target of halving the malaria burden by the
end of 2010 from the 2000 levels [5].
At the Abuja Summit in 2006 African Union Heads of
State and Government called for universal access to
HIV/AIDS, tuberculosis and malaria services by a united
Africa by 2010 and for a long-term vision on malaria
elimination [6]. In May 2007 the World Health Assem-
bly approved resolution WHA60.18 establishing the
World Malaria Day and urging all Member States to
apply a broad range of actions to scale up malaria con-
trol programmes and in particular to deploy recom-
mended artemisinin-based combination therapies and
progressively withdraw from the market oral artemisi-
nin-based monotherapies [7].
In 2008 the Global Malaria Action Plan was devel-
oped, and the malaria endemic countries developed road
maps to scale up cost-effective interventions towards
achieving the MDGs [8]. The same year the UN Secre-
tary General put forward a bold vision aimed at stop-
ping malaria deaths by ensuring universal coverage by
the end of 2010 [9]. This initiative was geared at (i)
offering indoor residue spraying and bed nets treated
with long-lasting insecticide to all people at risk, espe-
cially women and children in Africa, (ii) ensuring that
all public health facilities had access to effective malaria
treatment and diagnosis, (iii) providing ways to train
and retain community health workers dealing with
malaria, and (iv) encouraging research and development
for longer term efforts to control, eliminate and eradi-
cate malaria [9].
In September 2009 the 59th WHO Regional Commit-
tee for Africa adopted a resolution on Accelerated
Malaria Control, Towards Elimination in the African
Region, which calls for, among other actions, integration
of malaria control in poverty reduction strategies and all
national health and development plans and mobilization
of local resources for sustainable implementation of the
strategies [10].
On 23 September 2009 His Excellency President
Jakaya Kikwete of Tanzania, Past Chairman of the Afri-
can Union, launched the African Leaders Malaria Alli-
ance (ALMA) during the Sixty-fourth Session of the
United Nations General Assembly [11]. The purpose of
ALMA is to provide African leaders with a high-level
forum to ensure efficient procurement, distribution and
utilization of malaria control tools; facilitate the sharing
of effective malaria control practices; and ensure that
malaria remains high on the global policy agenda.
ALMA leaders subsequently met in February 2010 in
Addis Ababa, Ethiopia, to further refine their vision and
strategic agenda [12].
The ALMA working session at the 15th African Union
Summit in Kampala was held 25–26 July 2010 in the
context of calls for increasing efforts to accelerate pro-
gress towards MDGs 4 (reduce child mortality), 5
(improve maternal health and reduce maternal mortal-
ity) and 6 (combat HIV/AIDS, malaria and other dis-
eases in particular through halting and beginning to
reverse the incidence of malaria by 2015) and was in
line with the theme of the Summit, ‘Maternal, Infant
and Child Health and Development in Africa’.T h es e s -
sion agenda was also well aligned with the issues dis-
cussed at the previous satellite session on health
financing.
The purpose of this article is to reflect on the pro-
ceedings of the ALMA working session.
Methods
The session included speeches and statements by invited
speakers and high-level panel discussions. It was chaired
b yH i sE x c e l l e n c yJ a k a y aM r i sho Kikwete, President of
the United Republic of Tanzania. The panel comprised
the host of the African Union Summit, President Yoweri
Museveni of Uganda, President Robert Mugabe of Zim-
babwe and ministers of health and officials from African
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Raymond G. Chambers, UN Secretary General’s Special
Envoy for Malaria; Mrs Asha-Rose Migiro, UN Deputy
Secretary-General; Mrs. Obiageli Ezekwesili, World
Bank Vice President for Africa; Professor Michel
Kazatchkine, Executive Director of the Global Fund to
Fight Aids, Tuberculosis, and Malaria (GFATM); Mr
Kapembwa Simbao, Minister of Health of Zambia and
Chairman of the Roll Back Malaria Partnership Board;
Dr Luis Gomes Sambo, WHO Regional Director for
Africa; and Mrs Johannah-Joy Phumaphi, Executive
Secretary of ALMA.
Summary of presentations
Statement by His Excellency President Jakaya Mrisho
Kikwete
In his opening remarks, President Jakaya Mrisho Kik-
wete, stated [13]: “I see this meeting of ours today as
the watershed in our efforts and quest to control and
eliminate malaria in our respective countries and there-
fore in the entire African continent. By establishing
ALMA today, we are now creating a critical forum and
mechanism for advocacy, action, and follow-up on the
implementation of these noble goals.” He indicated that
mosquito net coverage in 20 African countries was at
least five times higher in 2010 than in 2000, leading to
significantly fewer cases of the disease and death. He
apprised that on the Tanzanian island of Zanzibar, the
combination of high mosquito net coverage, ACT avail-
ability and indoor residue spraying had reduced malaria
deaths by over 90%. More importantly, under-five deaths
from all causes fell by almost three-fifths.
President Kikwete underlined two strategic goals: (i) to
achieve universal mosquito net coverage by the end of
2010 and (ii) to eliminate preventable malaria deaths by
2015 by scaling up coverage of all other available interven-
tions (including access to rapid diagnostic tests, treatment
with artemisinin-based combination therapy, intermittent
preventive treatment and indoor residual spraying).
He acknowledged that these were audacious goals, but
with more than 680,000 African children dying each
year from malaria, audacity was a moral imperative. He
strongly advocated for malaria control as a step towards
achieving MDGs 4 (child mortality) and 5 (maternal
health). As convener of ALMA, President Kikwete noted
the tremendous contribution of the Global Fund to
Fight AIDS, Tuberculosis and Malaria (GFATM) and
the World Bank in helping to finance malaria control in
Africa. He expressed ALMA support for the full replen-
ishment of funding to both GFATM and the Interna-
tional Development Association of the World Bank.
Finally, President Kikwete called upon African leaders,
communities and partners to make a final push to reach
universal coverage of interventions against malaria.
Statement by Mr Raymond G. Chambers, UN Special
Envoy for Malaria
The UN Secretary General Special Envoy for Malaria
focused his statement on the need to achieve universal
coverage with essential interventions to end preventable
deaths due to malaria [14]. He highlighted the success
in procuring more than 200 million nets, including
through bulk purchasing. He reported on the MDG
meeting and stated that African leadership, represented
by ALMA, was a model that could be emulated to help
accelerate progress for the other health related MDGs.
Mr Chambers advocated for the remaining countries to
join ALMA and invited the Heads of States and Govern-
ment to the September 2010 UN General Assembly
MDG event.
Statement by Dr Asha-Rose Migiro, UN Deputy Secretary-
General
The UN Deputy Secretary-General, addressing the AU
leaders, indicated that the fight against malaria was
boosting women’s and children’s health [15]. She
applauded the successes reported in several African
countries and called upon the leadership of African
heads of states: “If you continue to see malaria control
as an integral part of reaching the Millennium Develop-
ment Goals … of building strong health systems … of
improving your people’sw e l l - b e i n g… then the success
we have seen to date will continue, and grow.” The UN
Deputy Secretary-General acknowledged that the fight
against malaria would be long, but she added: “We are
on the road to success. With perseverance, we will win.”
Statement by Mrs Obiageli Ezekwesili, Vice President of
the World Bank for Africa
The World Bank Vice President for Africa indicated that
the World Bank was making investments in malaria
control that would have returns both in terms of lives
saved and well beyond the health sector [16]. Those
investments are based on the evidence that malaria con-
trol contributes to health and development in Africa. Dr
Ezekwesili expressed the World Bank’s commitment to
strengthening support to ALMA as it deploys innovative
approaches to end deaths from malaria.
Statement by Professor Michel Kazatchkine, Executive
Director of GFATM
The Executive Director of GFATM presented recent evi-
dence on the impact of GFATM supported national
programmes in saving lives and contributing to health
systems and development [17]. He strongly advocated
for the support of recipient countries, bilateral and mul-
tilateral donors and the UN for the replenishment of the
fund in order to sustain the gains being made in disease
control and improvements in maternal and child health.
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WHO Regional Office for Africa
Dr Luis G. Sambo informed the session that the African
Region accounted for 85% of malaria episodes and 89%
of malaria deaths worldwide [18]. He reminded the
audience that approximately one in every five childhood
deaths was attributable to the effects of malaria and that
the disease could result in miscarriage, low birth weight
and maternal death rates ranging from 10 to 50%.
Malaria impacts negatively on MDGs 4 and 5. He
underscored the fact that the economic and health
losses associated with malaria were significant.
Dr Sambo reported that over the last decade, African
countries had scaled up proven malaria interventions,
which include vector control using long-lasting insecti-
cide-treated nets [19,20], indoor residue spraying [21],
intermittent preventive treatment in pregnancy [22] and
prompt and effective diagnosis and treatment [23].
Dr Sambo highlighted the encouraging achievements
of Botswana, Cape Verde, Eritrea, Namibia, Rwanda, Sao
Tome and Principe, South Africa, Swaziland, Zambia
and Zanzibar (Tanzania) in reducing the number of
malaria cases by at least 50% between 2000 and 2008
[24]. This success is associated with strong leadership
from heads of states and community leaders. He
encouraged the remaining countries to scale up the cov-
erage of interventions to reach universal coverage.
He informed the meeting that some countries were con-
templating the transition from sustained control to elimi-
nation of malaria owing to their very low malaria
transmission levels and based on robust epidemiological
evidence and feasibility assessments. Governments con-
templating the pursuit of malaria elimination will need to
secure adequate domestic and external funding for sus-
tained commitment; strengthen national malaria control
programmes in the context of broader health systems
strengthening; strengthen human resource capacity at cen-
tral, district and community levels; establish strong logis-
tic, information and surveillance systems as well as early
detection mechanisms for response to malaria epidemics
and complex emergencies; and forge effective cross-border
and trans national malaria control collaborative initiatives.
According to Dr Sambo, the use of oral artemisinin
monotherapy was a potential driver in emergence of resis-
tant malaria parasites. In May 2007 the World Health
Assembly adopted Resolution WHA60.18, which urged
Member States to deploy recommended artemisinin-based
combination therapies (ACTs) and withdraw oral artemisi-
nin-based monotherapies. He informed the meeting that
by July 2010, 30 countries in the African Region had taken
regulatory measures to withdraw oral artemisinin-based
monotherapies. He urged the remaining countries to
urgently develop similar policies to stop the marketing of
oral artemisinin-based monotherapies.
Dr Sambo cited a study that estimated at US$ 3 bil-
lion per year Africa’s need for global resources to
attain international malaria control goals. Financial
support to African countries for prevention and con-
trol of malaria totals approximately US$1.6 billion per
year and comes from GFATM, the US President’s
Malaria Initiative (PMI), the World Bank Booster Pro-
gramme for Malaria Control in Africa, the United
Kingdom Department for International Development
(DFID), Bill and Melinda Gates Foundation and other
agencies and foundations. He indicated that based on
the cost of an essential package of interventions, this
support represents 53% of the estimated financial
resources needed to reach global malaria control tar-
gets [25]. He appealed to external partners to support
countries to cover the funding gap of approximately
US$1.4 billion per year for universal coverage of key
malaria interventions and to boost capabilities for
attaining the MDG targets.
He concluded by appealing to the Heads of State to
foster leadership for improved intersectoral collabora-
tion to eliminate malaria as a public health problem in
Africa; increase domestic funding for malaria control
and accelerate progress towards MDGs 4, 5 and 6; sup-
port viable initiatives for local production of quality
medicines and other commodities; eliminate taxes and
tariffs on antimalarials and other public health essential
commodities; and ensure free access to malaria diagno-
sis and treatment for vulnerable groups such as children
and pregnant women, in addition to universal access to
long-lasting insecticide treated nets.
Statement by Mrs Johannah-Joy Phumaphi, ALMA
Executive Secretary
Mrs Johannah-Joy Phumaphi reported on the ALMA
call for immediate acceleration of procurement, ship-
ment and distribution of malaria commodities [26]. She
explained how the ALMA tender in collaboration with
UNICEF, WHO and ministers of health is building
capacity in participating countries. She identified the
gap between ownership of long-lasting insecticide trea-
ted nets and their effective use as a critical barrier to be
addressed by malaria programmes. She emphasized that
ALMA would continue to work with countries and part-
ners to ensure that communities were empowered to
hang, use and maintain the nets properly, and to disse-
minate best practices. She reported the commitment of
African ministers of heath, which was reiterated at the
Roll Back Malaria Board’s Special Session during the
African Union Summit.
Mrs Johannah-Joy Phumaphi expressed concern that
the high tariffs on commodities, such as bed nets and
antimalarial drugs, make them expensive and hamper
access. She cited the latest data that indicated that only
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tariffs.
Discussion
In his remarks to ALMA, Mr Kapembwa Simbao, Minis-
ter of Health of Zambia [27], expressed his support for
the ‘Actions for Accelerated Achievement of Maternal,
Newborn and Child Health and Development in Africa’
adopted by the AU to ensure achievement of the health
MDGs 4, 5 and 6 by 2015 [28].
Zimbabwe, Zambia, Rwanda, Nigeria, Mozambique,
Kenya and Mauritius presented their experiences in
scaling up of malaria control interventions, cross-border
collaboration and malaria elimination challenges. These
experiences revealed the link between malaria control
and maternal and child health. The debate provided
insights on the importance of implementing comprehen-
sive programmes, including community involvement, the
need to build adequate capacity for vector control, and
the use of rapid diagnostic tests. The role of nongovern-
mental organizations (NGOs) and public-private part-
nerships was also covered. The innovative approaches
highlighted included involvement of school children and
teachers in Mozambique, building capacity of village
health workers in Zimbabwe, fostering cross-border col-
laboration among Mozambique, Swaziland and South
Africa, and establishing model health centres in Kenya.
Mauritius talked on its efforts to prevent reintroduction
of malaria by using active surveillance and enforcing tra-
vel health regulations.
Cross-border collaboration is necessary for malaria
control in Africa because of the large negative external-
ities involved. Elimination of malaria in one country will
not be sustained if the neighbouring countries experi-
ence high transmission of malaria, as citizens mix freely
along borders, re-introducing malaria through travel and
migration. Cross-border mechanisms that could be
leveraged for controlling malaria already exist in the
African Region. There are two recent examples. First, on
18
th October 2010, the ministers of health from the
republics of Benin, Cameroon, Central African Republic,
Chad, Equatorial Guinea, Niger and Nigeria met in
Abuja and signed the Abuja Commitment on Cross-Bor-
der Public Health Issues. The countries represented
agreed to establish a joint initiative that permits multi-
sector involvement in prevention and control of multi-
ple public health problems in participating countries;
promote communities-based initiatives on information,
education and communication for disease prevention
and control; promote cross-border initiatives in early
detection of epidemics and improvement of water sup-
ply, sanitation and hygiene; advocate for operationaliza-
tion of the African Public Health Emergency Fund to
support emergency and cross-border public health
activities; strengthen National Disease Surveillance Sys-
tems and share information on cross border health
issues; establish National Agency for Drug Control and
inter-country multi-disciplinary committees to monitor
the quality of medicines and the circulation of counter-
feit medicines across borders; provide (on request) tech-
nical and logistics support to any of the participating
countries in the management of public health emergen-
cies; and appoint focal persons to constitute a commit-
tee to follow-up recommendations made in the inter-
ministerial meeting [29].
Second, on 18
th March 2011, the ministers of health
of the Republic of Angola, Republic of Congo, Demo-
cratic Republic of Congo, Republic of Namibia and
Republic of Zambia met in Lusaka and signed a Memor-
andum of Understanding (MOU) on Cross Border Pub-
lic Health Issues. The MOU touches on progress
towards achievement of health related MDGs; strength-
ening health systems to support cross border public
health issues; prevention and control of cholera and
other epidemic prone diseases; polio eradication; surveil-
lance and international health regulations; fake and
counterfeit medicines; and monitoring and evaluation of
cross border public health issues. Such mechanisms can
be used to mobilize domestic and external resources,
design, implement, monitor and report on cross-border
public health action against infectious diseases [30].
The country presentations echoed the sentiment of
the high-level panel that the burden of malaria should
be addressed as a priority health, social and develop-
mental issue and no longer as a fatality threat for Africa.
The need of tackling vector, parasite and host factors in
the context of specific environmental and climatic con-
ditions also was highlighted during the debate. Speakers
at the session emphasized the necessity of multi-
pronged approaches as the way forward to sustain the
gains in reduction of malaria morbidity and mortality.
There was agreement that the old but still valid notion
of the pathogenic malaria complex must remain at the
core of malaria control and elimination strategies [31].
The main bottlenecks identified by country represen-
tatives related to the capacity of the health systems to
deliver quality care and to issues of ensuring universal
access to diagnostic services and treatment. The partici-
pants unanimously agreed on the need for strong,
decentralized malaria-control programmes with linkages
with other health and development sectors, the civil
society and private sector entities. Recent publications
highlight the benefits of co-implementation of malaria
control programmes with child survival or other public
health interventions [10,32-34]. For example, on Bioko
Island in Equatorial Guinea and in the Chongwe district
area of Zambia, significant reduction of the malaria bur-
den has had a major impact on overall child survival.
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application of integrated promotive, preventive, diagnos-
tic and case management interventions with full com-
munity participation. In Zambia, malaria related
outpatient visits have reduced, and the reduction in
malaria cases at health facilities has led to an increase in
diagnoses of respiratory infections. These findings have
implications for the management of non-malaria fevers
in children under the age of five years. Similar data on
cost-effectiveness and impact of quality malaria diagnos-
tic and treatment are emerging in other countries
including Kenya, Senegal and Gambia [32-38]. Success-
ful experiences and best practices from Zanzibar (Tan-
zania), Ethiopia, Rwanda and Eritrea show that it is
possible to scale up essential interventions in the con-
text of existing programme structure while adapting
approaches to local political, socio-cultural and adminis-
trative environments [39-43].
However, it is important to acknowledge the chal-
lenges that have to be overcome in ensuring universal
access to malaria prevention and control services; and
getting people to use those services once access has
been assured. The first challenge is to develop sustain-
able health financing mechanisms that assure free
access to diagnosis, treatment and insecticide treated
nets for the poor. Such mechanisms may entail a com-
bination of social health insurance and tax funded
health services. In addition, health development part-
ners can complement government efforts by paying
social health insurance (or community health insur-
ance) premiums on behalf of the poor. Furthermore,
partners can reinforce national governments capacities
for providing free access for the poor through general
budget support. The second challenge draws attention
to the fact that even with free access, utilization may
be a problem because non-financial barriers to use of
diagnostic services and medication can be significant
[44]. The non-financial barriers (e.g. limited health-
related knowledge and awareness, behavioural factors,
cultural beliefs, geographic isolation) may be addressed
by leveraging health promotion methods and
approaches [45-47].
The success mentioned above has been made possible
by a number of enabling factors. First, existence of a
clear vision and effective leadership contributed to
improvement in the governance, stewardship and suc-
cess of national malaria control programmes. Second,
high level commitment has ensured relatively adequate
capacity in expertise, skill mix and number of managers,
technicians and service providers, including for commu-
nity interventions and case management. Third, national
ownership, intersectoral collaboration and accountabil-
ity, as well as strong civil society and private sector
involvement, are important attributes of well-performing
malaria control programmes. Fourth, successful pro-
grammes have the capacity to adjust to the rapidly
changing malaria epidemiology. Fifth, several regional
initiatives initiated with the support of AU and regional
economic communities contributed in addressing the
cross-border dimension of malaria control.
The panellist’s emphasized countries that had achieved
significant reductions in the malaria burden required
support to undertake programme assessments to ensure
sustained control and evidence-based transition to elimi-
nation of the disease. This requires in-depth programme
reviews, strengthening of capacity for surveillance moni-
toring and evaluation and intensification of cross-border
collaboration. It will entail contribution of research and
research based institutions in the collection, analysis and
dissemination of information for better control, adjust-
ments, and policy guidance.
The meeting was informed that the WHO regional
framework for the acceleration of malaria control
towards elimination and the guidelines on malaria elimi-
nation were available to guide the countries in planning,
implementation, monitoring and evaluation of malaria
programmes [48]. Moreover, WHO technical support is
available to the African Union to design relevant policies
and strategies, in particular the primary health care
approach for strengthening district health systems
[33,49]. Towards this endeavour, governments should
address the critical challenges including:
￿ Securing adequate domestic and external funding for
sustained commitment to malaria elimination;
￿ Strengthening national malaria control programmes
in the context of strengthening the broader health
system;
￿ Ensuring free access to malaria diagnosis and treat-
ment for vulnerable groups such as children and preg-
nant women in addition to universal access to long-
lasting insecticide treated nets;
￿ Strengthening human resource capacity at central,
district and community levels;
￿ Establishing strong logistics, information and surveil-
lance systems as well as early detection mechanisms for
response to malaria epidemics and other public health
threats.
Conclusions
A number of conclusions emerged from the discussions.
First, ALMA working sessions at the African Union
Summit were critically important for sustaining the
focus on accelerated malaria control and elimination
vision and strategy in support of actions at the country
level. Second, there is need for documenting and sharing
lessons learnt from African countries that have suc-
ceeded to dramatically reduce the burden of malaria.
T h i r d ,t h ea c h i e v e m e n t si ns o m ec o u n t r i e sc l e a r l y
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achievable if funding and ongoing interventions are sus-
tained. Lastly, there was a strong indication that the
next MDG summits will also offer a forum for strategic
projections and consolidation of financing and imple-
mentation pledges [50,51].
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